BrainChild Bio, Inc. logo

BrainChild Bio, Inc.

brainchildbio.com

BrainChild Bio develops CAR T-cell therapies for central nervous system tumors, prioritizing pediatric brain cancers such as diffuse intrinsic pontine glioma and extending its pipeline to adult tumors including glioblastoma and brain metastases. It aims to create safe and effective treatment options for children and adults with incurable brain tumors.

Facts

Sectors
Biotechnology Research
Employees
11–50
Stage
Series A
Founders
Michael Jensen, MD

Is this your organization? Claim it

Members see BrainChild Bio, Inc.'s funding rounds, amounts and investors.

People

  • Michael Jensen
    Michael Jensen Founder, Chief Scientific Officer
  • Steven Brugger Executive, Chief Executive Officer

Online